Introduction:

The global newborn screening market is poised for robust growth, projected to achieve a Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2030, reaching an estimated value of $2.49 billion by the end of the forecast period. This unprecedented expansion is attributed to several key factors, including the increasing prevalence of congenital heart diseases and genetic disorders, a growing neonatal population, and heightened awareness surrounding newborn screening. Despite the market's optimistic outlook, challenges such as a shortage of healthcare professionals and the emergence of non-invasive prenatal screening technologies pose impediments to growth. This blog explores the market dynamics and highlights the top 10 companies at the forefront of shaping the newborn screening landscape.

Top 10 Company List: https://meticulousblog.org/top-10-companies-in-newborn-screening-market

Thermo Fisher Scientific Inc. (U.S.):

Founded in 1956, headquartered in Massachusetts, U.S.

Operates in the newborn screening market through the Life Sciences Solutions segment.

Strong global presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

As of December 2022, the company employed 130,000 individuals worldwide.

ARCHIMED Group (France):

Established in 2014, headquartered in Lyon, France.

Global investment firm focusing on healthcare industry segments.

Acquired Natus Medical Incorporated in June 2022.

Manages companies such as Groupe CARSO (France), DIESSE Diagnostica Senese S.p.A. (Italy), and ZytoMax GmbH (Germany) in the newborn screening market.

PerkinElmer, Inc. (U.S.):

Founded in 1937, headquartered in Massachusetts, U.S.

Operates in the newborn screening market through the Diagnostics business segment.

Rebranded its life science and diagnostics businesses as Revvity in May 2023.

Global presence with manufacturing and R&D facilities in the U.S., China, Japan, and Germany.

Medtronic plc (Ireland):

Established in 1949, headquartered in Dublin, Ireland.

Healthcare technology company operating in four segments, including the Medical Surgical Portfolio.

Presence in the newborn screening market through the Medical Surgical Portfolio segment.

Divisions include Surgical Innovations and Respiratory, Gastrointestinal & Renal.

Trivitron Healthcare Pvt Ltd. (India):

Founded in 1997, headquartered in Tamil Nadu, India.

Medical technology company manufacturing products for In-Vitro Diagnostics, Imaging & Radiology, Newborn Screening, and more.

Global presence in over 180 countries with certified manufacturing facilities in India, the U.S., Finland, Turkey, and China.

Bio-Rad Laboratories, Inc. (U.S.):

Established in 1952, headquartered in California, U.S.

Distributor and manufacturer of clinical diagnostics products.

Operates in the newborn screening market through the Clinical Diagnostics segment.

Direct distribution in over 35 countries outside the U.S.

Demant A/S (Denmark):

Founded in 1904, headquartered in Hovedstaden, Germany.

Hearing healthcare and audio technology group operating in two business segments.

Presence in the newborn screening market through the Hearing Healthcare segment, divided into Hearing-Care, Hearing Aids, and Diagnostics.

Baebies, Inc. (U.S.):

Established in 2014, headquartered in North Carolina, U.S.

Medical technology company specializing in digital microfluidics for early disease detection.

Offers products and services for newborn and pediatric screening using platforms like Baebies FINDER and SEEKER systems.

ZenTech s.a. (Belgium):

Founded in 2001, headquartered in Liège, Belgium.

Biotechnology company specializing in In Vitro Diagnostics (IVD) and Radio Isotopic Assays (RIA) for prenatal, neonatal, and pediatric use.

Provides mass spectrometry and qPCR solutions for newborn screening laboratories.

Hoffmann-La Roche Ltd (Switzerland):

Established in 1896, headquartered in Basel, Switzerland.

Deals in pharmaceuticals and diagnostics with a global presence.

Operates in the newborn screening market through the Diagnostics segment, specifically the Molecular Lab segment.

Download Sample Report for the same: https://www.meticulousresearch.com/download-sample-report/cp_id=5367

Conclusion:

As the newborn screening market continues to expand, these ten companies play pivotal roles in shaping its trajectory. Their innovative solutions, global reach, and strategic initiatives position them as key players driving growth in this critical sector. Stay tuned for more insights into their recent financial performances, key products, strategic partnerships, and market influence in Meticulous Research®’s upcoming comprehensive report.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research